GUILDFORD, England and HAYWARD, Calif., April 17,
2024 /PRNewswire/ -- PeploBio and IncellDX are
launching the first laboratory developed test in the UK and EU to
help diagnose Long COVID, providing doctors with accurate insights
into personalised treatment approaches using the incellKINE Long
Hauler Index technology.
Long COVID affects more than 65 million worldwide. The typical
symptoms of Long COVID, ranging from fatigue, brain fog, shortness
of breath, insomnia, to a spectrum of cardiovascular issues, are
not exclusive to any single condition. This technological
breakthrough aims to provide physicians with a definitive tool to
differentiate Long COVID from other diseases sharing similar
symptoms such as Lyme and ME-CFS.
"Our collaboration with PeploBio marks a pivotal moment
in the battle against Long COVID. The incellKINE Long Hauler Index
technology enables us to identify a distinctive immunologic profile
unique to Long COVID patients, providing a crucial first step for
personalised treatment strategies," said Bruce Patterson, M.D., Founder and CEO at
IncellDX.
Dr. Nico Lambri, Managing Director at PeploBio said,
"Our mission at PeploBio is to drive innovation in diagnostics,
and our partnership with IncellDX underscores our commitment to
advancing healthcare solutions. The introduction of this test fills
a critical gap, empowering healthcare professionals with the tools
needed to address the challenges posed by Long
COVID."
About PeploBio
PeploBio is an ISO 15189 accredited clinical laboratory,
committed to elevating precision medicine and bringing innovative
diagnostic solutions to improve patient outcomes.
About IncellDX
IncellDx is a precision medicine company advancing novel
diagnostics and prognostics to better understand and treat
infectious disease and cancer. The company's innovative technology
platform enables simultaneous cell classification and single cell
analysis of proteomic and genomic biomarkers.
For media enquiries, please contact:
PeploBio:
|
IncellDX:
|
Jack Purvis
|
Julie
Ferguson
|
jpurvis@peplobio.co.uk
|
JFPRMEDIAGROUP
|
+44 (0)1483 685
190
|
julie@jfprmedia.com
|
|
(312)
385-0098
|
View original
content:https://www.prnewswire.com/news-releases/peplobio-and-incelldx-partner-to-launch-the-first-long-covid-test-in-the-uk-and-eu-302119442.html
SOURCE PeploBio